Breast Surgical Oncology Clinical Trials
Below is a list of breast cancer clinical trials run by the Breast Surgical Oncology department at MD Anderson. We have clinical trials for many different types of breast cancer including ductal carcinoma in situ (DCIS), HER2-positive, node-positive/HER-negative, lobular carcinoma, triple negative breast cancer and more.
Trial availability may change without notice. Individual trial spots may open or close without notice. Click on the study link for detailed information about each clinical trial.
Last updated 6/17/2020
DCIS
Study: ALLIANCE AFT-25
Phase III
Interventions: standard of care, active surveillance
Low-risk DCIS
NIH link: NCT02926911
Node +, HER2-
Lobular carcinoma
Study: 2018-0497
Phase II
Study agents: palbociclib, letrozole, tamoxifen, endocrine therapy
Lobular carcinoma
NIH link: NCT02764541
Lifestyle intervention
Study: ALLIANCE A011401
Phase III
Interventions: health education program, weight loss intervention
NIH link: NCT02750826
Subtype non-specific
Study: ALLIANCE A221702
Phase III
Intervention: isosulfan blue, axillary lymph node dissection, mapping
NIH link: NCT03927027
Study: ALLIANCE A011202
Phase III
Interventions: axillary lymph node dissection, radiation therapy
NIH link: NCT01901094
All Clinical Trials
MD Anderson patients have access to clinical trials offering research studies that cannot be found anywhere else.
Several other departments including Radiation Oncology, Investigational Cancer Therapeutics and Breast Medical Oncology also offer clinical trials that may be open to breast cancer patients.